MedTrace Logo

Acceptance and Commitment Therapy (ACT) for Anxious Cancer Survivors

NCT02550925 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 139

Last updated 2020-03-26

No results posted yet for this study

Summary

This randomized clinical trial compares group acceptance and commitment therapy (ACT) to usual care for cancer survivors experiencing anxiety following the end of cancer treatment.

Conditions

Interventions

BEHAVIORAL

Acceptance and Commitment Therapy (ACT) Group

A 7-session Acceptance and Commitment Therapy (ACT) group intervention

BEHAVIORAL

Usual Care

Check in with clinical social worker at oncology care site and obtain list of supportive resources

Sponsors & Collaborators

  • American Cancer Society, Inc.

    collaborator OTHER

  • Rocky Mountain Cancer Centers

    collaborator OTHER

  • University of California, Los Angeles

    collaborator OTHER

  • University of Colorado, Boulder

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2019-08-31
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02550925 on ClinicalTrials.gov